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Abstract 
Objective. Minimally invasive surgery is the method of choice in the management of 
hyperparathyroidism caused by parathyroid adenoma, whereas in case of parathyroid hyperplasia a 
radical operative procedure is necessary to prevent recurrence of the disease. The aim of the study 
was to investigate morphological and cytochemical parameters differentiating parathyroid adenoma 
from parathyroid hyperplasia in cytologic smears in preoperative work-up of patients with 
hyperparathyroidism.  
Methods. Fifty parathyroid cytologic smears, preoperatively obtained by ultrasound-guided 
aspiration biopsy, were analyzed. Fifty parathyroid cell nuclei per smear were analyzed, and the 
number of nucleolar organizer region (AgNOR) was determined using SFORM software (Vamstec, 
Zagreb). The results obtained were compared with histopathology findings.  
Results. The values of nuclear size parameters obtained by morphometric measurement revealed 
cells with larger nuclei and greater nuclear size diversity to be found in parathyroid adenoma, thus 
enabling differentiation of parathyroid hyperplasia from parathyroid adenoma in many cases. 
However, due to overlapping of borderline values, an attempt was made to reduce the possibility of 
error by determining AgNOR count and structure. The results obtained showed that neither AgNOR 
count, nor AgNOR classification into individual AgNOR, AgNOR clusters and annular AgNOR, had any 
role in differentiating parathyroid hyperplasia from parathyroid adenoma. 
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Parathyroid adenoma is mostly found as a 
solitary tumor, therefore minimally invasive 
surgery has been accepted as the method of 
choice in the management of 
hyperparathyroidism caused by parathyroid 
adenoma. In contrast, parathyroid hyperplasia 
usually develops as a secondary lesion 
characterized by diffuse or nodular hyperplasia 
of one or more parathyroid glands. Recurrence 
is known to occur in patients with parathyroid 
hyperplasia even after radical and properly 
performed surgery that required bilateral neck 
exploration, and such cases have been 
described in the literature, pointing to the 
importance of preoperative differentiation of 
parathyroid hyperplasia and parathyroid 
adenoma (1,2,3). Nucleolar organizer regions 
(AgNOR) are segments located on the short arm 
of acrocentric chromosomes in which the rRNA 
gene is located during the interphase and 
mitosis. These regions can be shown 
cytochemically by silver staining using the 
method of identifying non-histone, argyrophilic 
proteins connected with the sites of protein 
rRNA transcription (AgNOR). AgNORs play a 
significant role in nucleic acid transcription to 
proteins, thus their number may serve as an 
indicator of cell proliferation and tumor growth 
(4-7). The present study was focused on 
identification of new morphological parameters 
for differentiation of parathyroid hyperplasia 
from parathyroid adenoma in preoperative 
cytologic smears by determining the number 
and structure of AgNOR per nucleus. 
Material and Methods 
Fifty parathyroid gland smears obtained by 
ultrasound-guided fine-needle aspiration 
biopsy (US-FNAB) were included in the study. 
The histopathologic diagnosis was unknown. 
Study material was obtained by ultrasound-
guided fine-needle aspiration biopsy (UG-FNA) 
performed by a clinical cytologist (interventional 
cytologist) (8), who also performed the 
cytomorphological analysis of the material 
obtained. Each patient signed an informed 
consent form, while the study protocol was 
approved by the Hospital Ethics Committee and 
by the Zagreb School of Medicine Ethics 
Committee. US examinations were performed 
on an ACUSON X300 (Siemens, Erlangen, 
Germany) US device with 8.9 MHz and 11 MHz 
superficial tissue probes. UG-FNA was carried 
out by the free-hand technique (9). All smears 
were air dried and stained by the standard May-
Grünwald-Giemsa (MGG) method (10) and 
cytochemical method of selective silver staining 
of AgNOR. For the cytochemical method, slides 
previously stained by the standard MGG method 
were used for allowing selection of appropriate 
slides with an adequate number of preserved 
cells. The selected slides were immersed in a 
solution containing 1 part of 2% gelatin solution 
in 1% formic acid and two parts of 50% aqueous 
silver nitrate solution, and then left to stay in a 
dark chamber at room temperature for 45 
minutes. Then the slides were washed with 
distilled water and air dried (12). Upon silver 
impregnation, the AgNOR are seen as dark-
brown spots in the nucleus (Figure. 1). Each slide 
was examined under Olympus BX 50 
microscope connected to a computer image 
analyzer, initially at low magnification to select a 
representative area; then the selected area was 
systematically explored under immersion 
objective (magnification X1000) (11,14). In the 
present study, AgNOR analysis was performed 
by dividing them into three types: 1) 
homogeneous type (where dilutions were not 
even visible at magnification); 2) inhomogeneous 
Conclusion. Study results showed that AgNOR count and structure cannot help in determining more 
clearly the border between parathyroid adenoma and hyperplasia in cytologic smears. 
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type (irregular AgNOR dilutions visible at X1000 
and higher computer magnifications); and 3) 
annular AgNOR (annular configuration visible at 
standard magnification) (11,12). Intranuclear 
AgNOR number was determined for each 
AgNOR type. All patients were eventually 
treated surgically. Upon completion of testing, 
patients were divided into two groups based on 
histopathologic findings: parathyroid 
hyperplasia and parathyroid adenoma. The 
group of parathyroid hyperplasia included 36 
(72%) patients and the group of parathyroid 
adenoma included 14 (28%) patients. 
The basic descriptive parameters 
(minimal/maximal value and arithmetic mean) 
and variability measures (coefficient of variation 
and standard deviation) were calculated for 
each continuous variable. The pattern of 
distribution was assessed for each continuous 
variable. Determination was made of the mean 
value as a measure of central tendency and a 
central value based on the value size, as well as 
standard deviation (SD) as a measure of 
deviation of arithmetic means of samples from 
one population from arithmetic means of the 
other population. The correlation of continuous 
variables in the two groups was analyzed by the 
Mann-Whitney test as the most sensitive 
nonparametric test, along with the rank-sum 
calculation (13). 
Results 
Individual AgNOR count per nucleus was lower 
in the group of patients with parathyroid 
adenoma than in those with parathyroid 
hyperplasia, but the difference did not reach 
statistical significance (P=0.167) (Table 1). The 
mean number of AgNOR clusters was 
comparable in the two groups (P=0.763) (Table 
2). The mean number of individual AgNOR and 
AgNOR clusters, the number of AgNOR clusters 
and annular AgNOR, the number of individual 
and annular AgNOR, and the number of all 
AgNOR, were greater in the group of patients 
with parathyroid hyperplasia than in those with 
parathyroid adenoma; however, the difference 
was not statistically significant (P=0.257, P=0.846, 
P=0.151, P=0.158) (Table 3) (Fig. 2). 
Discussion 
Preoperative morphological finding of 
parathyroid hyperplasia or parathyroid adenoma 
is fundamental for further treatment of patients 
with hyperparathyroidism. Optimal patient 
management requires the highest possible 
differentiation between patients with 
parathyroid hyperplasia and those with 
parathyroid adenoma because minimally 
invasive surgery has been accepted as the 
method of choice in the management of 
hyperparathyroidism due to parathyroid 
adenoma, whereas recurrence is quite frequent 
in patients with parathyroid hyperplasia, thus 
Figure 1. PG Cells – AgNOR (Silver Nitrate, x1000) 
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demanding a radical surgical approach (1-3). On 








2.48 0.63 1.12 4.90 2.25 0.51 1.44 3.18 0.167 
 
*standard deviation; †Mann-Whitney test 
Table 2. Median of AgNOR cluster number according to patient groups 
Parameter 
Hyperplasia Adenoma P† 




1.00 1 - 1 0.00 1.25 1.00 1 - 1 0.00 1.14 0.763 
 
* interquartile range; †Mann-Whitney test 
Table 3. Median of AgNOR count according to patient groups 
Parameter 
Hyperplasia Adenoma P† 

















2.42 2.16-2.69 1.12 4.90 2.29 1.85-2.44 1.44 3.18 0.151 
Number of all 
AgNOR 
2.48 2.16-2.74 1.12 5.20 2.31 1.86-2.54 1.48 3.34 0.158 
 
* interquartile range; †Mann-Whitney test 
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the other hand, subtotal resection of parathyroid 
gland or complete excision with partial 
parathyroid autotransplantation is performed on 
surgical removal of enlarged parathyroid glands 
in order to prevent consequential 
hypoparathyroidism; therefore, parathyroid 
tumor should be differentiated preoperatively 
from hyperplastic tissue. On morphometric 
measurements performed by the system of 
image analysis, the subjective investigator's 
error is reduced by use of quantitative 
parameters. In our earlier research, subsequent 
correlation with histopathologic findings 
revealed higher values of nuclear area, 
circumference, minimal radius, convexity and 
width in the group of patients with parathyroid 
hyperplasia compared with the group of patients 
with parathyroid adenoma (14). When 
extrapolated to cell morphology in cytologic 
smear, cells with greater nuclei were found in 
the group with hyperplasia in relation to those 
found in the group with adenoma. In the group 
with parathyroid hyperplasia, higher values of 
standard deviation were recorded for each of 
these parameters compared to parathyroid 
adenoma; applied to cell morphology in 
cytologic smear, it indicates greater 
heterogeneity and size diversity in hyperplasia 
as compared with adenoma (14). However, as the 
borderline values of the parameters analyzed 
showed an occasional overlap, we tried to more 
clearly determine the border between adenoma 
and hyperplasia in cytologic smears using 
additionally the cytochemical method and 
determination of nuclear AgNOR count. As the 
AgNOR count correlates with the level of DNA 
transcription and degree of cell proliferation, the 
features of nuclear organization provide a way to 
simply distinguish resting cells from those 
involved in the cell cycle (4-7,15,16). Black spots 
can be visualized in all cells of parathyroid 
epithelium by staining the nucleoli and other 
structures of nucleolar organization. AgNOR 
clusters were only detected in proliferating cells 
of various tissues, whereas individual spots were 
found in mature, nonproliferating cells (17-20). 
These findings point to physiological differences 
between individual AgNOR and AgNOR clusters, 
thus justifying their separate evaluation. There 
are literature reports on the studies where 
AgNOR count per nucleus was determined in 
postoperative parathyroid histopathologic 
smears and significant difference was found 
between parathyroid carcinoma and benign 
parathyroid lesions, while no such difference in 
AgNOR count per nucleus was recorded 
between parathyroid adenoma and parathyroid 
hyperplasia (21,22). Boquist reports on the 
comparable AgNOR count per nucleus in 
parathyroid adenoma and liver adenoma (2.6 
and 2.3 AgNOR per nucleus, respectively), breast 
fibroadenoma and thyroid follicular adenoma 
(23). Mourad et al. have introduced the mean 
AgNOR (mAgNOR) count per nucleus, which 
correlates with ploidy (aneuploid cells have ≥2.4 
mAgNOR per cell and diploid cells <2.4 
mAgNOR per cell (24). In the present study, 
AgNOR analysis was performed by dividing 
them into three types: homogeneous, 
inhomogeneous and annular AgNOR (8). As 
AgNOR clusters are only found in proliferating 
cells, the number of AgNOR clusters is 
understandably low in adenoma and 
hyperplasia; instead, they are only found in 
individual cells. In our study, annular AgNOR 
were only detected in several individual nuclei. 
Irrespective of their number, all spots were 
enumerated and their role in differentiating 
parathyroid hyperplasia from parathyroid 
adenoma was assessed upon statistical data 
processing. The mean number of all AgNOR per 
nucleus was greater in parathyroid hyperplasia 
compared to parathyroid adenoma (2.48 vs. 2.31); 
the difference is not statistically significant 
(P=0.158) (Table 3) and is consistent with the 
values reported by Boquist in histopathologic 
material (23). Statistical data processing 
indicated the AgNOR classification according to 
their proliferation activity into individual AgNOR, 
AgNOR clusters and annular AgNOR to have no 
value in differentiating parathyroid hyperplasia 
and parathyroid adenoma. These cells are low-
proliferating cells predominated by 
homogeneous AgNOR, while AgNOR clusters 
and annular AgNOR are few and found in 
comparable number in both parathyroid 
hyperplasia and parathyroid adenoma. 
Cytologic smears are considered more 
appropriate for AgNOR determination than 
histologic sections because the spots are more 
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easily enumerated and individual spots are 
better visualized within the nucleoli in cytologic 
smears. In the latter, whole cells are seen, thus 
the number of spots is expectedly higher than in 
histologic sections. Yet, even materials that are 
so different can be compared if the ratio of 
AgNOR count and nucleus area is determined. 
This is of great value because there are few 
reports on studies performed on preoperatively 
obtained cytologic FNAB smears, thus obviating 
possible errors caused by different sample 
processing (25-27). Our own observations and 
subjective assessment that differences in 
nuclear size are substantial features to 
differentiate parathyroid adenoma and 
parathyroid hyperplasia in cytologic smear, and 
that these features can help differentiate these 
two entities in preoperative cytologic US-FNAB 
smears, were quantitatively confirmed by use of 
objective morphometric measurement and 
statistical analysis of the data obtained. Our 
results still point to justifiable utilization of 
cytodiagnosis, along with morphological and 
morphometric methods in the preoperative 
identification of parathyroid tumors. Particular 
nuclear morphometric parameters may 
influence the selection of patients as potential 
candidates for minimally invasive or radical 
surgical procedure (14). However, the borderline 
values of the study parameters may 
occasionally overlap, and quantitative 
determination of AgNOR per nucleus in 
preoperative cytologic smears cannot help in 
differentiating parathyroid adenoma from 
parathyroid hyperplasia, thus it cannot be used 
as a diagnostic criterion, which is consistent with 
literature data obtained on postoperative 
histopathology material (23,28,29). 
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